Gene · 21
NIH grants938
NIH grants whose papers are about the gene, through NIH's grant-paper links.
361 to 380 of 938
Download this page as JSON| Grant | Title | ABCA3 papers | Newest fiscal year |
|---|---|---|---|
| R01AI125197 | Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine | 1 | 2021 |
| R01AI129241 | Th9 cells in immediate hypersensitivity | 1 | 2021 |
| R01AI132178 | Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV | 1 | 2021 |
| R01CA204846 | Overcoming Cancer Resistance Mediated by the Human MDR1 Transporter | 1 | 2021 |
| R01CA211095 | Role of KDM5A in pRB-mediated differentiation | 1 | 2021 |
| R01DK076683 | Discover and functionally characterize full-penetrance causes of nephrosis / FSGS | 1 | 2021 |
| R01DK112782 | L-Cystine Diamides as Inhibitors of L-Cystine Stone Formation in Cystinuria | 1 | 2021 |
| R01DK120623 | Small molecules for expansion of islet beta-cell mass in diabetes | 1 | 2021 |
| R01EY028203 | Precision medicine for ABCA4 disease: modifier alleles | 1 | 2021 |
| R01GM123977 | Targeted regulation of transcript stability through RNA methylation and intron retention | 1 | 2021 |
| R01HL071798 | Pathogenesis of PCD Lung Disease | 1 | 2021 |
| R01HL137052 | Electronic Cigarette Vapor Inhalation Adversely Affects Lung Cellular and Physiologic Function and Alters Systemic Inflammatory Pathways | 1 | 2021 |
| R01HL138510 | 3'UTR Shortening in Pulmonary Vascular Disease | 1 | 2021 |
| R21AG069180 | ABCA7 dysfunction in Alzheimer's disease pathogenesis | 1 | 2021 |
| R21AI151486 | Mechanisms of immune dysregulation due to NFKB1 mutation in common variable immunodeficiency | 1 | 2021 |
| R21GM135668 | Affinity-Mediated Covalent Conjugation: A Method for Direct Modification of Specific Receptors on Cell Membranes | 1 | 2021 |
| R21HL153700 | Respiratory health and cigar and pipe use in the NHLBI Pooled Cohorts Study | 1 | 2021 |
| R25GM061838 | NIGMS RISE Program at the UPR Medical Sciences Campus | 1 | 2021 |
| R35CA197697 | Mechanisms of regulation by RNA in acute myeloid leukemia | 1 | 2021 |
| R35GM124898 | Mechanisms that govern assembly and function of higher order protein structures of purine metabolic enzymes | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/21/grants?page=19